Cryoport Inc
NASDAQ:CYRX
Intrinsic Value
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. [ Read More ]
The intrinsic value of one CYRX stock under the Base Case scenario is 21.88 USD. Compared to the current market price of 16.79 USD, Cryoport Inc is Undervalued by 23%.
Valuation Backtest
Cryoport Inc
Run backtest to discover the historical profit from buying and selling CYRX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Cryoport Inc
Current Assets | 535.1m |
Cash & Short-Term Investments | 456.8m |
Receivables | 42.1m |
Other Current Assets | 36.3m |
Non-Current Assets | 422.6m |
PP&E | 117.5m |
Intangibles | 302.8m |
Other Non-Current Assets | 2.3m |
Current Liabilities | 45.6m |
Accounts Payable | 27m |
Accrued Liabilities | 16.8m |
Other Current Liabilities | 1.8m |
Non-Current Liabilities | 423.1m |
Long-Term Debt | 380.8m |
Other Non-Current Liabilities | 42.3m |
Earnings Waterfall
Cryoport Inc
Revenue
|
233.3m
USD
|
Cost of Revenue
|
-133.9m
USD
|
Gross Profit
|
99.3m
USD
|
Operating Expenses
|
-164.9m
USD
|
Operating Income
|
-65.6m
USD
|
Other Expenses
|
-42m
USD
|
Net Income
|
-107.6m
USD
|
Free Cash Flow Analysis
Cryoport Inc
What is Free Cash Flow?
CYRX Profitability Score
Profitability Due Diligence
Cryoport Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Cryoport Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
CYRX Solvency Score
Solvency Due Diligence
Cryoport Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Cryoport Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CYRX Price Targets Summary
Cryoport Inc
According to Wall Street analysts, the average 1-year price target for CYRX is 18.7 USD with a low forecast of 15.15 USD and a high forecast of 23.1 USD.
Ownership
CYRX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
CYRX Price
Cryoport Inc
Average Annual Return | 39.12% |
Standard Deviation of Annual Returns | 105.85% |
Max Drawdown | -89% |
Market Capitalization | 822.2m USD |
Shares Outstanding | 49 164 500 |
Percentage of Shares Shorted | 9.94% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 791 full-time employees. The company went IPO on 2015-07-24. The firm provides supply chain technologies and services through its brands, such as Cryoport Systems, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. The firm's products include Cryoport Express Shippers, Cryoport ELITE Shippers, Cryoport Cryosphere, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature Controlled Logistics, CRYOPDP Direct to Patient Solutions, CRYOPDP Control Tower Solution, MVE Biological Solutions Fusion Cryogenic Freezers and MVE Biological Solutions Vario Cryogenic Freezer. The company operates primarily in Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Its subsidiaries include Cryoport Systems, LLC, Cryogene, Inc., MVE Biological Solutions, US LLC, Cryoport Netherlands B.V., and Cell&Co BioServices.
Contact
IPO
Employees
Officers
The intrinsic value of one CYRX stock under the Base Case scenario is 21.88 USD.
Compared to the current market price of 16.79 USD, Cryoport Inc is Undervalued by 23%.